Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13768
Title: Temozolomide-associated liver fibrosis
Austin Authors: Parakh, Sagun ;Hamid, Anis A;Cher, Lawrence M ;Gan, Hui K 
Affiliation: Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia
Issue Date: Nov-2016
metadata.dc.date: 2016-04-20
Publication information: The Journal of Clinical Pharmacology 2016; 56(11): 1448-1449
Abstract: Temozolomide is generally well tolerated and severe hepatic toxicities associated with temozolomide are rare. We report a case of liver fibrosis in a patient on temozolomide for the treatment of GBM. This article is protected by copyright. All rights reserved.
URI: http://ahro.austin.org.au/austinjspui/handle/1/13768
DOI: 10.1002/jcph.753
ORCID: 0000-0002-7193-9723
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/27094014
Type: Journal Article
Subjects: Temozolomide
Liver Cirrhosis
Appears in Collections:Journal articles

Show full item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.